Fundraising FoxPromptly
3 known investors
Find your way into Promptly
Sign up to find every way you can get introduced to Promptly
- Your email: who you already know at Promptly, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Promptly team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
Investors · 3
Nina Capitallisted by Nina CapitalBarcelona · $215K – $1.6M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Promptly do?
- Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
- Who are Promptly's investors?
- Promptly's investors include Kfund, Nina Capital, Shilling VC.